Please select the option that best describes you:

What is your preferred dose and fractionation schedule for a patient with a stage III non-small cell lung cancer, whose comorbidities preclude chemotherapy, but has good enough performance status to warrant an attempt at longer-term local control?  

What dose is preferred for central stage III NSCLC without chemotherapy? Do you recommend higher dose hypofractionated RT or conventional RT? 



Answer from: Radiation Oncologist at Academic Institution
Sign in or Register to read more

Answer from: Radiation Oncologist at Academic Institution
Sign in or Register to read more

Answer from: Radiation Oncologist at Academic Institution
Comments
Radiation Oncologist at Loma Linda University
What cardiac constraints do you use with those alt...
Sign in or Register to read more

Answer from: Radiation Oncologist at Community Practice
Comments
Radiation Oncologist at Radiation Oncology of Rochester, PLLC
Thank you for the helpful information with referen...
Radiation Oncologist at Summit Medical Center
Very well written.
Sign in or Register to read more

Answer from: Radiation Oncologist at Community Practice
Sign in or Register to read more

Answer from: Radiation Oncologist at Academic Institution
Sign in or Register to read more